跳到正文
原文
Endpoints News 生物医药· Max Bayer·· 2026-10-13AI 评分50

Asahi Kasei Therapeutics 近 10 亿美元收购的疱疹新疗法获 FDA 批准

Asahi Kasei lands approval for new HSV treatment

AI 导读

日本药企 Asahi Kasei Therapeutics 的疱疹治疗药物获 FDA 批准。该药是公司今年早些时候以近 10 亿美元交易收购所得。

正文

Japan­ese phar­ma Asahi Ka­sei Ther­a­peu­tics has snagged FDA ap­proval for a her­pes treat­ment that it ac­quired ear­ly this year in an al­most $1 bil­lion deal.

…

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news